Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (2464)	7/26/2018 12:57:29 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 3559

<What exactly do you mean by, "no clear cut"?> What fixed dose and what interval (6 or 9 or ??? months) will they used in PDS p3 trial? 40mg and 100mg conc. appears the same, still some subjects will be overdosed, some underdosed based and data presented. Without intermediate subjects control, 1, 2 or 3 months interval there is no a good way to control outcome...max benefit of the system. Also, how many refill implant can sustain??